Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease.

Villella VR, Venerando A, Cozza G, Esposito S, Ferrari E, Monzani R, Spinella MC, Oikonomou V, Renga G, Tosco A, Rossin F, Guido S, Silano M, Garaci E, Chao YK, Grimm C, Luciani A, Romani L, Piacentini M, Raia V, Kroemer G, Maiuri L.

EMBO J. 2019 Jan 15;38(2). pii: e100101. doi: 10.15252/embj.2018100101. Epub 2018 Nov 29.

2.

A new case report of severe mucopolysaccharidosis type VII: diagnosis, treatment with haematopoietic cell transplantation and prenatal diagnosis in a second pregnancy.

Furlan F, Rovelli A, Rigoldi M, Filocamo M, Tappino B, Friday D, Gasperini S, Mariani S, Izzi C, Bondioni MP, Gellera C, Venerando A, Villa N, Del Carmen Rodriguez Perez M, Pavan F, Biondi A, Parini R.

Ital J Pediatr. 2018 Nov 16;44(Suppl 2):128. doi: 10.1186/s13052-018-0566-x.

3.

The Golgi 'casein kinase' Fam20C is a genuine 'phosvitin kinase' and phosphorylates polyserine stretches devoid of the canonical consensus.

Cozza G, Moro E, Black M, Marin O, Salvi M, Venerando A, Tagliabracci VS, Pinna LA.

FEBS J. 2018 Dec;285(24):4674-4683. doi: 10.1111/febs.14689. Epub 2018 Nov 20.

PMID:
30387551
4.

Dependence of HSP27 cellular level on protein kinase CK2 discloses novel therapeutic strategies.

Borgo C, Vilardell J, Bosello-Travain V, Pinna LA, Venerando A, Salvi M.

Biochim Biophys Acta Gen Subj. 2018 Dec;1862(12):2902-2910. doi: 10.1016/j.bbagen.2018.09.014. Epub 2018 Sep 20.

PMID:
30279146
5.

Adult leukoencephalopathies with prominent infratentorial involvement can be caused by Erdheim-Chester disease.

Chiapparini L, Cavalli G, Langella T, Venerando A, De Luca G, Raspante S, Marotta G, Pollo B, Lauria G, Cangi MG, Gerevini S, Botturi A, Pareyson D, Dagna L, Salsano E.

J Neurol. 2018 Feb;265(2):273-284. doi: 10.1007/s00415-017-8692-8. Epub 2017 Dec 4.

PMID:
29204962
6.

CK2 is a key regulator of SLC4A2-mediated Cl-/HCO3- exchange in human airway epithelia.

Ibrahim SH, Turner MJ, Saint-Criq V, Garnett J, Haq IJ, Brodlie M, Ward C, Borgo C, Salvi M, Venerando A, Gray MA.

Pflugers Arch. 2017 Sep;469(9):1073-1091. doi: 10.1007/s00424-017-1981-3. Epub 2017 Apr 28.

7.

From phosphoproteins to phosphoproteomes: a historical account.

Venerando A, Cesaro L, Pinna LA.

FEBS J. 2017 Jul;284(13):1936-1951. doi: 10.1111/febs.14014. Epub 2017 Feb 11. Review.

8.

The Selectivity of CK2 Inhibitor Quinalizarin: A Reevaluation.

Cozza G, Venerando A, Sarno S, Pinna LA.

Biomed Res Int. 2015;2015:734127. doi: 10.1155/2015/734127. Epub 2015 Oct 19.

9.

Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation.

De Stefano D, Villella VR, Esposito S, Tosco A, Sepe A, De Gregorio F, Salvadori L, Grassia R, Leone CA, De Rosa G, Maiuri MC, Pettoello-Mantovani M, Guido S, Bossi A, Zolin A, Venerando A, Pinna LA, Mehta A, Bona G, Kroemer G, Maiuri L, Raia V.

Autophagy. 2014;10(11):2053-74. doi: 10.4161/15548627.2014.973737.

10.

Casein kinase: the triple meaning of a misnomer.

Venerando A, Ruzzene M, Pinna LA.

Biochem J. 2014 Jun 1;460(2):141-56. doi: 10.1042/BJ20140178. Review.

PMID:
24825444
11.

Expanding sialidosis spectrum by genome-wide screening: NEU1 mutations in adult-onset myoclonus.

Canafoglia L, Robbiano A, Pareyson D, Panzica F, Nanetti L, Giovagnoli AR, Venerando A, Gellera C, Franceschetti S, Zara F.

Neurology. 2014 Jun 3;82(22):2003-6. doi: 10.1212/WNL.0000000000000482. Epub 2014 May 7. Review.

PMID:
24808020
12.

A "SYDE" effect of hierarchical phosphorylation: possible relevance to the cystic fibrosis basic defect.

Venerando A, Cesaro L, Marin O, Donella-Deana A, Pinna LA.

Cell Mol Life Sci. 2014 Jun;71(12):2193-6. doi: 10.1007/s00018-014-1581-8. Epub 2014 Feb 25.

PMID:
24566881
13.

Phosphorylation of cystic fibrosis transmembrane conductance regulator (CFTR) serine-511 by the combined action of tyrosine kinases and CK2: the implication of tyrosine-512 and phenylalanine-508.

Cesaro L, Marin O, Venerando A, Donella-Deana A, Pinna LA.

Amino Acids. 2013 Dec;45(6):1423-9. doi: 10.1007/s00726-013-1613-y. Epub 2013 Nov 1.

PMID:
24178769
14.

Detection of phospho-sites generated by protein kinase CK2 in CFTR: mechanistic aspects of Thr1471 phosphorylation.

Venerando A, Franchin C, Cant N, Cozza G, Pagano MA, Tosoni K, Al-Zahrani A, Arrigoni G, Ford RC, Mehta A, Pinna LA.

PLoS One. 2013 Sep 18;8(9):e74232. doi: 10.1371/journal.pone.0074232. eCollection 2013.

15.

Pyrvinium pamoate does not activate protein kinase CK1, but promotes Akt/PKB down-regulation and GSK3 activation.

Venerando A, Girardi C, Ruzzene M, Pinna LA.

Biochem J. 2013 May 15;452(1):131-7. doi: 10.1042/BJ20121140.

PMID:
23438105
16.

CFTR mutations altering CFTR fragmentation.

Tosoni K, Stobbart M, Cassidy DM, Venerando A, Pagano MA, Luz S, Amaral MD, Kunzelmann K, Pinna LA, Farinha CM, Mehta A.

Biochem J. 2013 Jan 1;449(1):295-305. doi: 10.1042/BJ20121240.

17.

Inhibition of protein kinase CK2 by flavonoids and tyrphostins. A structural insight.

Lolli G, Cozza G, Mazzorana M, Tibaldi E, Cesaro L, Donella-Deana A, Meggio F, Venerando A, Franchin C, Sarno S, Battistutta R, Pinna LA.

Biochemistry. 2012 Aug 7;51(31):6097-107. Epub 2012 Jul 25.

PMID:
22794353
18.

Interaction between the SH3 domain of Src family kinases and the proline-rich motif of HTLV-1 p13: a novel mechanism underlying delivery of Src family kinases to mitochondria.

Tibaldi E, Venerando A, Zonta F, Bidoia C, Magrin E, Marin O, Toninello A, Bordin L, Martini V, Pagano MA, Brunati AM.

Biochem J. 2011 Nov 1;439(3):505-16. doi: 10.1042/BJ20101650.

PMID:
21732913
19.

Understanding protein kinase CK2 mis-regulation upon F508del CFTR expression.

Venerando A, Pagano MA, Tosoni K, Meggio F, Cassidy D, Stobbart M, Pinna LA, Mehta A.

Naunyn Schmiedebergs Arch Pharmacol. 2011 Oct;384(4-5):473-88. doi: 10.1007/s00210-011-0650-x. Epub 2011 May 24. Review.

20.

Isoform specific phosphorylation of p53 by protein kinase CK1.

Venerando A, Marin O, Cozza G, Bustos VH, Sarno S, Pinna LA.

Cell Mol Life Sci. 2010 Apr;67(7):1105-18. doi: 10.1007/s00018-009-0236-7. Epub 2009 Dec 30. Erratum in: Cell Mol Life Sci. 2011 Mar;68(5):919.

PMID:
20041275
21.

Modulation of mitochondrial K(+) permeability and reactive oxygen species production by the p13 protein of human T-cell leukemia virus type 1.

Silic-Benussi M, Cannizzaro E, Venerando A, Cavallari I, Petronilli V, La Rocca N, Marin O, Chieco-Bianchi L, Di Lisa F, D'Agostino DM, Bernardi P, Ciminale V.

Biochim Biophys Acta. 2009 Jul;1787(7):947-54. doi: 10.1016/j.bbabio.2009.02.001. Epub 2009 Feb 11.

22.

Identification of novel protein kinase CK1 delta (CK1delta) inhibitors through structure-based virtual screening.

Cozza G, Gianoncelli A, Montopoli M, Caparrotta L, Venerando A, Meggio F, Pinna LA, Zagotto G, Moro S.

Bioorg Med Chem Lett. 2008 Oct 15;18(20):5672-5. doi: 10.1016/j.bmcl.2008.08.072. Epub 2008 Aug 26.

PMID:
18799313
23.

Chemical dissection of the APC Repeat 3 multistep phosphorylation by the concerted action of protein kinases CK1 and GSK3.

Ferrarese A, Marin O, Bustos VH, Venerando A, Antonelli M, Allende JE, Pinna LA.

Biochemistry. 2007 Oct 23;46(42):11902-10. Epub 2007 Oct 2.

PMID:
17910481
24.

The first armadillo repeat is involved in the recognition and regulation of beta-catenin phosphorylation by protein kinase CK1.

Bustos VH, Ferrarese A, Venerando A, Marin O, Allende JE, Pinna LA.

Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19725-30. Epub 2006 Dec 15.

25.

Antibodies to tissue transglutaminase C in type I diabetes.

Lampasona V, Bonfanti R, Bazzigaluppi E, Venerando A, Chiumello G, Bosi E, Bonifacio E.

Diabetologia. 1999 Oct;42(10):1195-8.

PMID:
10525659
26.

Comparison of tissue transglutaminase-specific antibody assays with established antibody measurements for coeliac disease.

Bazzigaluppi E, Lampasona V, Barera G, Venerando A, Bianchi C, Chiumello G, Bonifacio E, Bosi E.

J Autoimmun. 1999 Feb;12(1):51-6.

PMID:
10028022
27.

[Areas of intervention: production and preparation of foodstuffs, industry, sports, work, mass media].

Ricci G, Costantini AM, Cantarelli C, Pallotta U, Carnacini A, Marcelli E, Venerando A, Zeppilli P, Angela P, Gobbato F.

G Ital Cardiol. 1989 Sep;19(9):825-41; discussion 842-50. Italian. No abstract available.

PMID:
2612826
28.

[Mitral valve prolapse and sports: introduction].

Venerando A.

Cardiologia. 1985 Nov;30(11):959-61. Italian. No abstract available.

PMID:
3834988
29.

Physiological adaptation of the venous system in sportsmen.

Venerando A, Pelliccia A.

J Sports Med Phys Fitness. 1983 Mar;23(1):1-7. No abstract available.

PMID:
6876782
30.

Screening for Mitral Valve Prolapse.

Zeppilli P, Venerando A.

Phys Sportsmed. 1982 Jan;10(1):29. doi: 10.1080/00913847.1982.11947143. No abstract available.

PMID:
29267117
31.

Sudden death and physical exertion.

Zeppilli P, Venerando A.

J Sports Med Phys Fitness. 1981 Sep;21(3):299-300. No abstract available.

PMID:
7321563
32.

[Physiopathology of superficial venous circulation in athletes].

Venerando A, Pelliccia A.

Phlebologie. 1981 Apr-Jun;34(2):289-98. French.

PMID:
7301930
33.

[Regional dilatation of the superficial venous circulation in athletes: phenomenon of vascular adaptation to training].

Venerando A, Pelliccia A.

Boll Soc Ital Cardiol. 1981;26(12):2169-71. Italian. No abstract available.

PMID:
7185385
34.

Frank vectorcardiogram in athletes of different sport activities.

Zeppilli P, Pirrami MM, Sassara M, Venerando A.

J Sports Med Phys Fitness. 1979 Dec;19(4):371-80. No abstract available.

PMID:
541996
35.

A scintigraphic study of the pulmonary blood flow in endurance athletes at rest and after exercise.

Todaro A, Pigorini F, Rossi F, Venerando A.

J Sports Med Phys Fitness. 1979 Dec;19(4):327-40. No abstract available.

PMID:
541991
36.

Electrocardiography in sports medicine.

Venerando A.

J Sports Med Phys Fitness. 1979 Jun;19(2):107-28. Review. No abstract available.

PMID:
388079
37.

Radiological investigations in pulmonary circulation of endurance athletes: a preliminary report.

Rossi F, Todaro A, Venerando A.

J Sports Med Phys Fitness. 1977 Sep;17(3):269-74. No abstract available.

PMID:
607003
38.

[Study of the analgesic activity of DL-2(3-phenoxyphenyl) propionic acid].

Santilli G, Venerando A.

Clin Ter. 1975 Dec 31;75(6):587-601. Italian. No abstract available.

PMID:
767042
39.

Fundamental aspects of the role and organisation of sports medicine.

Venerando A.

J Sports Med Phys Fitness. 1975 Mar;15(1):68-74. No abstract available.

PMID:
1152453
40.

[Physical education].

Venerando A.

Riv Med Aeronaut Spaz. 1974 Jul-Dec;37(3-4):323-5. Italian. No abstract available.

PMID:
4470234
41.

[Physical activity deficiencies].

Venerando A.

Minerva Med. 1973 Sep 22;64(66):3452-9. Italian. No abstract available.

PMID:
4746871
42.

[Use of 2-(4-isobutylphenyl)-propionic acid (brufen) in the treatment of some diseases of athletes].

Venerando A, Santilli G.

Minerva Med. 1973;64(48):2537-9. Italian. No abstract available.

PMID:
4726746
43.

[Prevention and treatment of hypokinetic disease].

Venerando A.

Recenti Prog Med. 1972 Apr;52(4):350-61. Italian. No abstract available.

PMID:
5068412
44.

Twin studies in sport and physical performance.

Venerando A, Milani-Comparetti M.

Acta Genet Med Gemellol (Roma). 1970 Jan-Apr;19(1):80-2. No abstract available.

PMID:
5533801
45.

[Anthropometric, spirometric and dynamometric data of subjects undergoing physical training during development].

Dal Monte A, Bracci C, Caldarone G, Angella F, Venerando A.

Cas Lek Cesk. 1970 Jan;109(5):104-7. Czech. No abstract available.

PMID:
5418745
46.

Classification and methods for the detection of some doping agents.

Venerando A, Gesmundo F, Cavalli A.

J Sports Med Phys Fitness. 1969 Dec;9(4):245-52. No abstract available.

PMID:
5377150
47.

[Rehabilitation of the cardiopathic patient. I].

Rulli V, Venerando A.

Cardiol Prat. 1968 Feb;19(1):1-16. Italian. No abstract available.

PMID:
5685524
48.

[Changes in some electrocardiographic indices in acclimation to an average altitude].

Severini V, Dal Monte A, Venerando A.

Boll Soc Ital Biol Sper. 1967 Jun 30;43(12):712-5. Italian. No abstract available.

PMID:
6080725
49.

[Action of amphetamine on muscular work eficiency in man. VI. Observations on the pulse-oxygen index].

Venerando A, Gesmundo F, Dal Monte A.

Boll Soc Ital Biol Sper. 1967 May 15;43(9):457-60. Italian. No abstract available.

PMID:
6053251
50.

[Action of amphetamine on muscular work efficiency in man. V. Observations on the ventilatory equivalant].

Venerando A, Gesmundo F, Dal Monte A.

Boll Soc Ital Biol Sper. 1967 May 15;43(9):454-7. Italian. No abstract available.

PMID:
6053250

Supplemental Content

Loading ...
Support Center